Back to Authors

Hussain, Fareeda Taher Nazer

Mayo Clinic

Mayo Clinic in Arizona

Citations 2

Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease
Yab, Tracy C. , Hussain, Fareeda Taher Nazer, Garrity-Park, Megan, Sandborn, William J. , Loftus, Edward V. , Wolff, B. G., Smyrk, Thomas C. , Zou, Hongzhi , Ahlquist, David A. , Kisiel, John B. , Taylor, William R. , Itzkowitz, Steven H. , Rubin, David T. , Mahoney, Douglas W. , Loftus, Edward V

Alimentary Pharmacology & Therapeutics | January 24, 2013 | Volume: 37 | Issue: 5 | Pages: 546-554

10.1111/apt.12218 Get It

SummaryBackgroundCurrent approaches to the detection of colorectal neoplasia associated with inflammatory bowel disease (IBD‐CRN) are suboptimal.AimTo test the feasibility of using stool assay of exfoliated DNA markers to detect IBD‐CRN.MethodsThis investigation comprised tissue and stool studies. In the tissue study, gene sequencing and methylation assays were performed on candidate genes using tissue DNA from 25 IBD‐CRNs and from 25 IBD mucosae without CRN. Mutations on p53, APC, KRAS, BRAF or PIK3CA genes were insufficiently informative, but several aberrantly methylated genes were highly discriminant. In the stool study, we evaluated candidate methylated genes (vimentin, EYA4, BMP3, NDRG4) in a prospective blinded study on buffered stools from 19 cases with known IBD‐CRN and 35 age‐ and sex‐matched IBD controls without CRN. From stool‐extracted DNA, target genes were assayed using quantitative allele‐specific real‐time target and signal amplification method.ResultsIBD‐CRN cases included 17 with ulcerative colitis (UC) and two with Crohn's disease (CD); nine had cancer and 10 had dysplasia. Controls included 25 with UC and 10 with CD. Individually, BMP3, vimentin, EYA4 and NDRG4 markers showed high discrimination in stools with respective areas under the ROC curve of 0.91, 0.91, 0.85 and 0.84 for total IBD‐CRN and of 0.97, 0.97, 0.95 and 0.85 for cancer. At 89% specificity, the combination of BMP3 and mNDRG4 detected 9/9 (100%) of CRC and 80% of dysplasia, 4/4 (100%) of high grade and 4/6 (67%) of low grade.ConclusionThese findings demonstrate the feasibility of stool DNA testing for non‐invasive detection of colorectal neoplasia associated with inflammatory bowel disease.
Surgical Repair of Tetralogy of Fallot at Age 83
Hussain, Fareeda Taher Nazer, Grogan, Martha , Dearani, Joseph A.

World Journal for Pediatric and Congenital Heart Surgery | October 25, 2012 | Volume: 3 | Issue: 4 | Pages: 518-520

10.1177/2150135112451031 Get It

Tetralogy of Fallot (TOF) is a cyanotic congenital heart defect typically diagnosed in infancy and treated with early surgical correction. We report a patient with TOF diagnosed at age 78. Successful surgical repair was performed at age 83, the oldest reported age of surgical correction of this condition. Despite a complicated surgical and postoperative course, the patient is doing well almost four years later.